🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.

Experimental Treatment Acquiring Traction Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Sellers market the substance there before directing buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals administering substances of uncertain source.

Several professionals said the demand for retatrutide could be connected to the rising cost of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or imprisonment.

Service Response and Content Removal

Based on TikTok, the service has removed violative material and banned associated keywords and search suggestions. The company said it was dedicated to keeping the service safe and investing in strengthening enforcement strategies.

Digital Trading Operations

Investigations also discovered groups with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays channels with numerous of members, filled with photos of slimming results, positive testimonials and step-by-step instructions for preparing or injecting at residence.

Within moments of entering one group, a vendor posted contact information, where most purchases occur. The vendor provided an guidebook and promised delivery within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.

Product Details and Costs

Within these groups, posts display black plastic parcels with postal service labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When questioned how long a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for Telegram stated it actively moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they can’t verify. Although the research behind retatrutide is sound, these online products may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has already seen patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may subject patients to potentially serious health risks”.